FreeStyle Libre portfolio has been extensively studied with the most real-world users, delivering proven health outcomes FreeStyle Libre 2 system includes a self-applied sensor (the size of two-stacked quarters) that is easiest glucose sensor to apply and worn on the back of the upper arm, eliminating the need for painful fingersticks to test glucose levels Now for children (ages 4 and older) and adults with diabetes, this latest technology is the first and only iCGM that sustains performance for up to 14 days, providing trends, insights and actionable data FreeStyle Libre 2 is the only integrated continuous glucose monitoring (iCGM) system available that continuously transmits glucose data every minute with customizable, optional real-time alarms to alert users when their glucose is high or low without scanning ![]() for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards – by Regina Schafferĭisclosure: Watkin is an employee of Abbott.Abbott's FreeStyle® Libre 2 iCGM Cleared in U.S. Near-field communication (NFC)-enabled phones on Apple’s iPhone 7 and later, running iOS 11 and later. The FreeStyle LibreLink app is compatible with that did not require finger-stick calibration for adults with diabetes. The FDA approved a 10-day version of the CGM system in September 2017, making it the first CGM system in the U.S. That approval made Abbott’s continuous glucose monitor the longest-lasting, self-applied personal glucose sensor available on the market, with improved accuracy and reduced warmup time. The Android version of the app is currently under development.Īs Endocrine Today previously reported, the FDA in July approved the FreeStyle Libre flash glucose monitoring system, which allows patients with diabetes to wear the sensor up to 14 days with high accuracy. Once available, patients will be able to pair the FreeStyle Libre or FreeStyle Libre 14-day sensors with the app. 0.5 U), and support for 26 languages.įreeStyle LibreLink users also have the option to automatically share their glucose information with their health care professional and caregivers.įreeStyle LibreLink app will be free to download through the Apple App Store in the coming weeks, according to Abbott. This is another step forward in making glucose monitoring seamlessly fit into a patient’s daily lifestyle - helping them live a fuller, healthier life.”Īccording to the press release, The FreeStyle LibreLink app has several new features as compared with the FreeStyle Libre and FreeStyle Libre 14-day readers, including a larger, high-resolution display, text-to-speech capabilities for glucose readings (when enabled), the ability to log smaller doses of insulin (0.1 U vs. ![]() “The FreeStyle LibreLink app is a digital health tool that integrates glucose data directly on a compatible smartphone so all of the mobile apps that people use every day are in one convenient place. “We’re committed to liberating people from the many hassles of diabetes management through our life-changing technology and tools,” Jared Watkin, senior vice president of Diabetes Care at Abbott, said in the release. The FreeStyle LibreLink app also includes a series of in-app reports that visualize trends and patterns to help patients understand how well they are controlling their glucose. The FreeStyle LibreLink app enables users to hold their iPhone near their FreeStyle Libre or FreeStyle Libre 14-day sensor to instantly capture and view their real-time glucose levels, assess their 8-hour glucose history, and see a directional arrow indicating how their glucose is changing, according to the release. The FDA approved a mobile app for use with the Freestyle Libre 10-day and 14-day glucose monitoring systems, allowing patients with diabetes to monitor glucose readings on their compatible iPhone devices, Abbott announced in a press release. ![]() If you continue to have this issue please contact to Healio
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |